NCT06056791
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06056791
Title Study of INKmune in Patients With mCRPC (CaRe Prostate) (CaRe)
Acronym CaRe
Recruitment Active, not recruiting
Gender male
Phase Phase Ib/II
Variant Requirements No
Sponsors Inmune Bio, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
VA Greater Los Angeles Healthcare System Los Angeles California 90073 United States Details
University of California, Los Angeles Los Angeles California 90095 United States Details
Comprehensive Cancer Centers of Nevada Las Vegas Nevada 89169 United States Details
Carl & Edyth Lindner Center for Research and Education at The Christ Hospital and The Christ Hospital Cancer Center Cincinnati Ohio 45219 United States Details
Renovatio Clinical El Paso Texas 79915 United States Details
Renovatio Clinical The Woodlands Texas 77380 United States Details
NEXT Virginia Fairfax Virginia 22031 United States Details
VA Puget Sound Health Care System Seattle Washington 98108 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field